- Research works
- 46 ▲ 276% vs 2013–17
- Citations
- 415 9.0 per fractional work
- Top-10% rate
- 8.5% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Real Prevention (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 5.7×. Every wedge is a field page.
- Dentistry 5.7×
- Psychology 3.5×
- Medicine 2.6×
- Health Professions 2.3×
- Economics, Econometrics and Finance 2.1×
- Veterinary 2.0×
- Earth and Planetary Sciences 1.3×
- Arts and Humanities 1.1×
- Business, Management and Accounting 1.1×
- Social Sciences 1.0×
- Immunology and Microbiology 0.9×
- Neuroscience 0.5×
- Environmental Science 0.4×
- Agricultural and Biological Sciences 0.2×
- Decision Sciences 0.1×
- Biochemistry, Genetics and Molecular Biology 0.1×
- Engineering 0.0×
Which keywords describe research at Real Prevention (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Lymphoma, PET Imaging, Classification, Molecular Profiling, Prognostic Factors, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- Substance Use Disorders
- Chronic Lymphocytic Leukemia
- Prognostic Factors
- Classification
- Lymphoma
- Rituximab
- PET Imaging
- Molecular Profiling
- Epidemiology
- Genomic Aberrations
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 10 words, with their numbers
- Rituximab4▲ 128×2 topics
- Lymphoma3▲ 83×2 topics
- PET Imaging3▲ 78×2 topics
- Classification3▲ 28×1 topic
- Molecular Profiling3▲ 131×1 topic
- Prognostic Factors2▲ 18×5 topics
- Epidemiology2▲ 1.93×11 topics
- Chronic Lymphocytic Leukemia1▲ 140×1 topic
- Genomic Aberrations1▲ 140×1 topic
- Substance Use Disorders1▲ 73×2 topics
Which research topics does Real Prevention (United States) publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Media Influence and Health and Opioid Use Disorder Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 3 Media Influence and Health Literature and Literary Theory 1 works
- 4 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 1 works
- 5 Substance Abuse Treatment and Outcomes Epidemiology 0 works
- 6 Eating Disorders and Behaviors Clinical Psychology 0 works
- 7 Reconstructive Facial Surgery Techniques Surgery 0 works
- 8 Dental Implant Techniques and Outcomes Oral Surgery 0 works
- 9 Nasal Surgery and Airway Studies Surgery 0 works
- 10 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Real Prevention (United States)'s research output changed?
Output in 2018–2022 was 276% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.